The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin
Abstract
We previously have found that advanced glycation end products (AGE), senescent macroproteins formed at an accelerated rate in diabetes, arise in vivo not only from glucose but also from reducing sugars. Furthermore, we recently have shown that glyceraldehyde‐ and glycolaldehyde‐derived AGE (glycer‐ and glycol‐AGE) are mainly involved in loss of pericytes, the earliest histopathological hallmark of diabetic retinopathy. However, the effects of these AGE proteins on angiogenesis, another vascular derangement in diabetic retinopathy, remain to be elucidated. In this study, we investigated whether these AGE proteins elicit changes in cultured endothelial cells that are associated with angiogenesis. When human skin microvascular endothelial cells (EC) were cultured with glycer‐AGE or glycol‐AGE, growth and tube formation of EC, the key steps of angiogenesis, were significantly stimulated. The AGE‐induced growth stimulation was significantly enhanced in AGE receptor (RAGE)‐overexpressed EC. Furthermore, AGE increased transcriptional activity of nuclear factor‐κB (NF‐κB) and activator protein‐1 (AP‐1) and then up‐regulated mRNA levels of vascular endothelial growth factor (VEGF) and angiopoietin‐2 (Ang‐2) in EC. Cerivastatin, a hydroxymethylglutaryl CoA reductase inhibitor; pyrrolidinedithiocarbamate; or curcumin was found to completely prevent the AGE‐induced increase in NF–κB and AP‐1 activity, VEGF mRNA up‐regulation, and the resultant increase in DNA synthesis in microvascular EC. These results suggest that the AGE‐RAGE interaction elicited angiogenesis through the transcriptional activation of the VEGF gene via NF‐κB and AP‐1 factors. By blocking AGE‐RAGE signaling pathways, cerivastatin might be a promising remedy for treating patients with proliferative diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Self-citationAngiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989 · cited 2×
“Internal oligodeoxyribonucleotide probes were 5'-TGTTGAGACCCAGGTTACTAA-3' for detecting Ang-1 cDNA, 5’-TCCACAGAGGCAGAACACAA-3' for detecting Ang-2 cDNA, and 5'-TCCTTCCTACCAGCTACTT-3' for detecting Tie-2 cDNA, corresponding to nt 750-769 (20), nt 1729-1748 (21), and nt 515-534 (22), respectively.”
BackgroundPROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
Zhang, F. L., & Casey, P. J. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.001325 · Cited by 1,743
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Benjamin, L. E., Hemo, I., & Keshet, E. (1998) · Development · doi:10.1242/dev.125.9.1591 · Cited by 1,265
Blood Vessel Formation: What Is Its Molecular Basis?
Folkman, J., & D'Amore, P. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81810-3 · Cited by 1,215
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 918
Self-citationLander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813
Retinal Vascular Patterns: IV. Diabetic Retinopathy
COGAN, D. G. (1961) · Archives of Ophthalmology · doi:10.1001/archopht.1961.00960010368014 · Cited by 803
Yoshida, S., Ono, M., Shono, T., Izumi, H., Ishibashi, T., Suzuki, H., & Kuwano, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4015 · Cited by 696
Dyer, D. G., Blackledge, J. A., Thorpe, S. R., & Baynes, J. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99007-1 · Cited by 535
Oh, H., Takagi, H., Suzuma, K., Otani, A., Matsumura, M., & Honda, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15732 · Cited by 499
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11771 · Cited by 475
Self-citationBucala, R., Makita, Z., Vega, G., Grundy, S., Koschinsky, T., Cerami, A., & Vlassara, H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9441 · Cited by 474
Self-citationGrandhee, S. K., & Monnier, V. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99006-x · Cited by 459
Advanced glycation end products increase retinal vascular endothelial growth factor expression.
Lu, M., Kuroki, M., Amano, S., Tolentino, M., Keough, K., Kim, I., Bucala, R., & Adamis, A. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1277 · Cited by 423
Self-citationTie receptors: new modulators of angiogenic and lymphangiogenic responses
Jones, N., Iljin, K., Dumont, D. J., & Alitalo, K. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35067005 · Cited by 418
Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B.
Fujita, T., Nolan, G. P., Ghosh, S., & Baltimore, D. (1992) · Genes & Development · doi:10.1101/gad.6.5.775 · Cited by 369
Nomura, M., Yamagishi, S.-I., Harada, S.-I., Hayashi, Y., Yamashima, T., Yamashita, J., & Yamamoto, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28316 · Cited by 297
Self-citationAdvanced Glycation End Products-driven Angiogenesis in Vitro
Yamagishi, S.-I., Yonekura, H., Yamamoto, Y., Katsuno, K., Sato, F., Mita, I., Ooka, H., Satozawa, N., Kawakami, T., Nomura, M., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8723 · Cited by 276
Self-citationMechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
Saaristo, A., Karpanen, T., & Alitalo, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203969 · Cited by 264
Hemoglobin-AGE: A Circulating Marker of Advanced Glycosylation
Makita, Z., Vlassara, H., Rayfield, E., Cartwright, K., Friedman, E., Rodby, R., Cerami, A., & Bucala, R. (1992) · Science · doi:10.1126/science.1411574 · Cited by 251
Self-citationYamagishi, S.-I., Amano, S., Inagaki, Y., Okamoto, T., Koga, K., Sasaki, N., Yamamoto, H., Takeuchi, M., & Makita, Z. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6312 · Cited by 209
Self-citationVincent, L., Chen, W., Hong, L., Mirshahi, F., Mishal, Z., Mirshahi-Khorassani, T., Vannier, J.-P., Soria, J., & Soria, C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02337-7 · Cited by 201
Yamagishi, S., Fujimori, H., Yonekura, H., Yamamoto, Y., & Yamamoto, H. (1998) · Diabetologia · doi:10.1007/s001250051089 · Cited by 194
Self-citationTakeuchi, M., Makita, Z., Bucala, R., Suzuki, T., Koike, T., & Kameda, Y. (2000) · Molecular Medicine · doi:10.1007/bf03401779 · Cited by 192
Self-citationBancroft, C. C., Chen, Z., Dong, G., Sunwoo, J. B., Yeh, N. T., Park, C., & Waes, C. V. (2001) · PubMed · Cited by 178
Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells
Chua, C. C., Hamdy, R. C., & Chua, B. H. L. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(97)00129-8 · Cited by 178
Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions.
Yamagishi, S., Yonekura, H., Yamamoto, Y., Fujimori, H., Sakurai, S., Tanaka, N., & Yamamoto, H. (1999) · PubMed · Cited by 143
Self-citationIchiki, T., Takeda, K., Tokunou, T., Iino, N., Egashira, K., Shimokawa, H., Hirano, K., Kanaide, H., & Takeshita, A. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1201.099430 · Cited by 130
Duyndam, M. C. A., Hulscher, T. M., Fontijn, D., Pinedo, H. M., & Boven, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106282200 · Cited by 126
Yamagishi, S., Hsu, C., Taniguchi, M., Harada, S. I., Yamamoto, Y., Ohsawa, K. S., Kobayashi, K. I., & Yamamoto, H. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2185 · Cited by 126
Self-citationTakeuchi, M., Makita, Z., Yanagisawa, K., Kameda, Y., & Koike, T. (1999) · Molecular Medicine · doi:10.1007/bf03402128 · Cited by 122
Self-citationAdvanced Glycation Endproducts Accelerate Calcification in Microvascular Pericytes
Yamagishi, S., Fujimori, H., Yonekura, H., Tanaka, N., & Yamamoto, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0625 · Cited by 107
Self-citationZiegler, S. F., Ta, B., Ja, S., Schooley, K., & Pr, B. (1993) · PubMed · Cited by 106
Kawahara, A., Minami, Y., Miyazaki, T., Ihle, J. N., & Taniguchi, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8724 · Cited by 103
Endothelin-1 Mediates Endothelial Cell-Dependent Proliferation of Vascular Pericytes
Yamagishi, S., Hsu, C., Kobayashi, K., et al. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1293 · Cited by 69
Self-citation王, 英. (2001) · Institutional Repositories DataBase (IRDB) · Cited by 68
Yamagishi, S.-I., Yamamoto, Y., Harada, S.-I., Hsu, C., & Yamamoto, H. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00279-7 · Cited by 47
Self-citation
Cited by
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
Role of advanced glycation end products in cellular signaling
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.016 · Cited by 1,150
“cells Angiogenesis 100 mg/ml -Increased expression vascular endothelial growth factor (VEGF) and angiopoietin-2 [226]”
BackgroundBoulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913
Gupta, S. C., Kim, J. H., Prasad, S., & Aggarwal, B. B. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9235-2 · Cited by 806
Vascular endothelial growth factor in eye disease
Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 762
Metadata
- Authors
- Okamoto, T., Yamagishi, S., Inagaki, Y., Amano, S., Koga, K., Abe, R., Takeuchi, M., Ohno, S., Yoshimura, A., & Makita, Z.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2002-10-04
- Volume
- 16
- Issue
- 14
- Pages
- 1928-1930
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2133857970
- Cited by
- 258
- References
- 43
- FWCI
- 9.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.